This was followed by an increase in the expression of glutamate synthase (GS), which converted Glu to glutamine (Gln), subsequently releasing it into the extracellular space, where it was reabsorbed into the presynaptic terminal of glutamatergic neurons in the nigrostriatal pathway in PD animal models. The gene discussed is GLUL; the disease is Parkinson disease.